Nuvation Bio (NUVB)
(Real Time Quote from BATS)
$3.00 USD
+0.01 (0.33%)
Updated Jun 14, 2024 01:26 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
NUVB 3.00 +0.01(0.33%)
Will NUVB be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for NUVB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NUVB
Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know
Nuvation Bio Inc. (NUVB) Upgraded to Buy: What Does It Mean for the Stock?
NUVB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NUVB
Nuvation Bio rises 7.2%
Fly Intel: After-Hours Movers
Nuvation Bio director buys $500K in common stock
TD Cowen Sticks to Its Buy Rating for Nuvation Bio (NUVB)
Buy Rating for Nuvation Bio on Taletrectinib’s Promising NSCLC Treatment Efficacy and Favorable Financial Outlook